Navigation Links
PCMA: Independent Drugstore Lobby Continues 'Disclosure Double Standard' Transparency Campaign

WASHINGTON, Dec. 7, 2010 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) issued the following statement on today's U.S. Department of Labor (DOL) hearing:

"The independent drugstore lobby continues its 'disclosure double standard' campaign of opposing pricing transparency for themselves in Medicaid while demanding more transparency for pharmacy benefit managers (PBMs). This campaign puts its Congressional and retail pharmacy allies in the embarrassing role of attacking and defending the same policy, depending on whether it applies to them or other members of the pharmacy supply chain.

"While the federal 'transparency' provision in the health care law already applies to PBMs -- but not independent retailers -- an interesting irony remains: independent drugstores are themselves the least 'transparent' part of today's pharmacy supply chain.

"Unlike independent drugstores, PBMs are hired by payers to drive down prescription costs, not maximize reimbursements. The Federal Trade Commission (FTC), Government Accountability Office (GAO), Congressional Budget Office (CBO), the Office of Inspector General (OIG), and the Centers for Medicare & Medicaid Services (CMS) have all recognized proven PBM tools generate savings for public and private payers.

"PBMs support policies that empower payers to make informed health care purchasing decisions. However, so-called 'transparency' proposals that would give drugstores and drugmakers access to competitive information would undermine these efforts and only increase prices. The FTC has explored this issue and concluded that the PBM market is extremely competitive and that this kind of 'transparency' would increase, not decrease, costs for consumers."

PCMA represents the nation's pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 200-plus million Americans.

SOURCE Pharmaceutical Care Management Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Independent Clinical Results Demonstrate Outstanding Effectiveness of INVOcell Process
2. NCPA Announces Partnership with Live Oak Bank to Help Finance Independent Community Pharmacy Purchases
3. NCPA Digest Finds Independent Community Pharmacies Stable Despite Economic, Third-Party Challenges
4. Mid*Lands IRB, LLC - First Independent IRB in Kansas and the Kansas City Area Awarded Accreditation for Protecting Research Participants
5. Independent Community Pharmacies Earn High Customer Satisfaction Scores in Latest J.D. Power and Associates National Pharmacy Study
6. Independent Study Concludes Medicare Competitive Bidding Program for Durable Medical Equipment Could Negatively Affect Care Access, Quality, and Choice for Seniors and People with Disabilities
7. Phase 3 Trial of Aflibercept in Second-Line Metastatic Colorectal Cancer to Continue as Planned at Recommendation of Independent Data Monitoring Committee
8. NCPA Launches to Connect Independent Pharmacy Buyers and Sellers
9. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
10. K-V Pharmaceutical Company Announces the Nomination and Appointment of New Independent Member to the Board of Directors
11. Abviva Engages W.T. Uniack & Co. As Independent Auditor
Post Your Comments:
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
Breaking Medicine News(10 mins):